JPH0240986B2 - - Google Patents

Info

Publication number
JPH0240986B2
JPH0240986B2 JP63188510A JP18851088A JPH0240986B2 JP H0240986 B2 JPH0240986 B2 JP H0240986B2 JP 63188510 A JP63188510 A JP 63188510A JP 18851088 A JP18851088 A JP 18851088A JP H0240986 B2 JPH0240986 B2 JP H0240986B2
Authority
JP
Japan
Prior art keywords
ala
polypeptide
glu
leu
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63188510A
Other languages
English (en)
Japanese (ja)
Other versions
JPH01173871A (ja
Inventor
Ryuuningu Byorun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bonnierforetagen AB
Original Assignee
Bonnierforetagen AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bonnierforetagen AB filed Critical Bonnierforetagen AB
Publication of JPH01173871A publication Critical patent/JPH01173871A/ja
Publication of JPH0240986B2 publication Critical patent/JPH0240986B2/ja
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP63188510A 1979-04-20 1988-07-29 合成ポリペプチドからなる癌診断剤 Granted JPH01173871A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7903505 1979-04-20
SE7903505-1 1987-04-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP5222880A Division JPS55141452A (en) 1979-04-20 1980-04-18 Synthetic polypeptide

Publications (2)

Publication Number Publication Date
JPH01173871A JPH01173871A (ja) 1989-07-10
JPH0240986B2 true JPH0240986B2 (OSRAM) 1990-09-14

Family

ID=20337858

Family Applications (2)

Application Number Title Priority Date Filing Date
JP5222880A Granted JPS55141452A (en) 1979-04-20 1980-04-18 Synthetic polypeptide
JP63188510A Granted JPH01173871A (ja) 1979-04-20 1988-07-29 合成ポリペプチドからなる癌診断剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP5222880A Granted JPS55141452A (en) 1979-04-20 1980-04-18 Synthetic polypeptide

Country Status (9)

Country Link
US (1) US4327075A (OSRAM)
JP (2) JPS55141452A (OSRAM)
CA (1) CA1157465A (OSRAM)
CH (1) CH645880A5 (OSRAM)
DE (1) DE3014582A1 (OSRAM)
FR (1) FR2454436A1 (OSRAM)
GB (1) GB2047713B (OSRAM)
IT (1) IT1141277B (OSRAM)
SE (1) SE447263B (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
ZA814637B (en) * 1980-07-17 1982-08-25 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
ZA84617B (en) * 1983-02-14 1984-09-26 Arup Sen Synthetic polypeptides from viryl oncogenes
US4859765A (en) * 1983-10-17 1989-08-22 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
CA1256795A (en) * 1983-12-28 1989-07-04 Dennis A. Carson Anti-idiotype antibodies induced by synthetic polypeptides
US5055396A (en) * 1987-11-03 1991-10-08 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
AU3413989A (en) * 1988-03-29 1989-10-16 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485810A (en) * 1967-07-24 1969-12-23 Lilly Co Eli Novel amino acid protecting groups
US4028315A (en) * 1970-10-16 1977-06-07 E. R. Squibb & Sons, Inc. Solid phase synthesis of peptides
US3912711A (en) * 1972-07-03 1975-10-14 Susan E Leeman Synthetically produced undecapeptide, Substance P
US3960827A (en) * 1972-07-10 1976-06-01 Bjoerklund K B Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
US4160018A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Stabilized cancer associated polypeptide antigen and preparation thereof
US3915949A (en) * 1974-02-12 1975-10-28 Armour Pharma Solid phase synthesis of ACTH
US3926938A (en) * 1974-08-12 1975-12-16 Armour Pharma Synthesis of salmon calcitonin
US4062746A (en) * 1975-05-07 1977-12-13 Wisconsin Alumni Research Foundation Solid phase synthesis of protected peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4031070A (en) * 1976-03-01 1977-06-21 Parke, Davis & Company Tetrapeptides
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4174385A (en) * 1976-10-08 1979-11-13 Robert Reid Method of identification of surface proteins of cancer cells, clinical test and method of immunization

Also Published As

Publication number Publication date
DE3014582A1 (de) 1980-10-30
IT1141277B (it) 1986-10-01
JPS55141452A (en) 1980-11-05
FR2454436B1 (OSRAM) 1983-06-10
CH645880A5 (de) 1984-10-31
SE8002726L (sv) 1980-10-21
FR2454436A1 (fr) 1980-11-14
DE3014582C2 (OSRAM) 1990-11-08
JPS6364440B2 (OSRAM) 1988-12-12
SE447263B (sv) 1986-11-03
GB2047713A (en) 1980-12-03
US4327075A (en) 1982-04-27
GB2047713B (en) 1983-02-02
JPH01173871A (ja) 1989-07-10
IT8021411A0 (it) 1980-04-16
CA1157465A (en) 1983-11-22

Similar Documents

Publication Publication Date Title
US4107298A (en) Antigenically active polypeptide and a process for its preparation
EP0458841B1 (en) Method for the use and synthesis of peptides
Barany et al. Solid‐phase peptide synthesis: a silver anniversary report
EP0138855A1 (en) METHOD FOR DETERMINING ANTIGENICALLY ACTIVE AMINO ACID SEQUENCES.
JPH06501938A (ja) ペプチドよりなるｈｉｖ複製阻害剤
US20130310314A1 (en) Solid phase synthesis of h(gly2)glp-2
JPS62120399A (ja) 抗原決定ペプチド及びそれらの製造方法
JPS63225397A (ja) 抗アレルギー作用を有する新規ペプチド
JPH03503047A (ja) ポリマーおよびポリマー‐ペプチド複合体
JPH0240986B2 (OSRAM)
NO149998B (no) Analogifremgangsmaate til fremstilling av peptider med ubiquitinlignende aktivitet
CN100357313C (zh) 非靶位点胺基被保护的肽,其制备方法以及使用该肽制备特异性地结合的peg肽的方法
JPS61246199A (ja) 免疫原性ｈａｖペプチド
US20050004040A1 (en) Peptide having an affinity for gp120
Drijfhout et al. Solid-phase synthesis and applications of N-(S-acetylmercaptoacetyl) peptides
JPH0372496A (ja) 固相多重ペプチド合成
JPH02229200A (ja) 抗アレルギー作用を有するペプチド
JP2680446B2 (ja) 固相ペプチド合成法
Fontana et al. Covalent Binding of Polypeptides to Sulfonium Resins
JPH0338599A (ja) 抗ｈｉｖペプチド及び抗ｈｉｖ修飾ペプチド
Love Studies towards the chemical synthesis of the 18 kDa antigenic protein from Mycobacterium leprae: a thesis presented in partial fulfilment of the requirements for the degree of Ph. D. in Chemistry at Massey University
CS258290B1 (cs) Peptid s vlastnostmi antigennlch determinant a způsob jeho výroby
JPH0416480B2 (OSRAM)
JPH05125096A (ja) ペプチドおよびそれを含んでなるエイズ診断用要素
CS258288B1 (cs) Peptid s vlastnostmi antigennich determinant a způsob jeho výroby